Femoston 1/10 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
13多発性硬化症/視神経脊髄炎1

13. 多発性硬化症/視神経脊髄炎


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-005129-10-FI
(EUCTR)
27/01/201512/12/2014Multiple Sclerosis, menopause and hormone replacement therapyMultiple Sclerosis and Menopause: the effect of hormone replacement therapy on clinical picture and immunology of multiple sclerosis Multiple sclerosis
MedDRA version: 17.1;Level: LLT;Classification code 10064137;Term: Progression of multiple sclerosis;System Organ Class: 100000004852
MedDRA version: 17.1;Classification code 10070425;Term: Multiple sclerosis exacerbation;System Organ Class: 100000004852;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Femoston 2/10
Product Name: Femoston 2/10
INN or Proposed INN: ESTRADIOL HEMIHYDRATE
INN or Proposed INN: DYDROGESTERONE
Trade Name: Femoston 1/10
Product Name: Femoston 1/10
INN or Proposed INN: ESTRADIOL HEMIHYDRATE
INN or Proposed INN: DYDROGESTERONE
Irina ElovaaraNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: no
Finland